dimethoxyphenylethylamine has been researched along with 2-(4-iodo-2,5-dimethoxyphenyl)-n-(2-methoxybenzyl)ethanamine in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 32 (80.00) | 24.3611 |
2020's | 8 (20.00) | 2.80 |
Authors | Studies |
---|---|
Begtrup, M; Ettrup, A; Gillings, N; Hansen, M; Knudsen, GM; Kornum, BR; Madsen, J; Någren, K; Palner, M; Rasmussen, LK; Santini, MA | 1 |
Poklis, A; Poklis, JL; Rose, SR | 1 |
Blain, P; Doris, T; Dunn, M; Gurung, S; Hill, SL; Katebe, S; Lomas, A; Thomas, SH | 1 |
Hegarty, CB; Janis, GC; Kealey, SE; Stellpflug, SJ | 1 |
Barratt, MJ; Bright, SJ; Caldicott, DG | 1 |
Arbefeville, EF; Devers, KG; Houston, E; Pearson, JM; Poklis, A; Poklis, JL | 1 |
Chen, HH; Gonsoulin, ML; Lopez, AE; Phillips, GT; Sanchez, LA; Walterscheid, JP | 1 |
Athanaselis, S; Nikolaou, P; Papoutsis, I; Spiliopoulou, C; Stefanidou, M | 1 |
Forrester, MB | 1 |
Calvo, J; Elbakoush, F; Exantus-Bernard, G; Fong, J; Laskowski, LK; Nelson, LS; Poklis, A; Poklis, JL | 1 |
Cooke, CT; Kueppers, VB | 1 |
Cumpston, KL; Hieger, MA; Miller, S; Rose, SR; Stromberg, PE; Wills, BK | 1 |
Auwärter, V; Brandt, SD; Caspar, AT; Helfer, AG; Maurer, HH; Meyer, MR; Michely, JA | 1 |
Althauser, S; Boulos, N; Collison, K; Davis, MC; Hedrick, R; IsHak, WW | 1 |
Behonick, GS; Shanks, KG; Sozio, T | 1 |
Dempsey, SK; Liu, K; Poklis, A; Poklis, JL; Ritter, JK; Wolf, C; Zhang, S | 1 |
Alford, KN; Peace, MR; Poklis, A; Poklis, JL; Raso, SA | 1 |
Couper, FJ; Lowe, LM; Peterson, BL | 1 |
Barrington, S; Gee, P; Jensen, BP; Moore, G; Schep, LJ | 1 |
Holm, NB; Kristensen, JL; Leth-Petersen, S; Linnet, K; Nielsen, LM; Olsen, L | 1 |
Andersson, M; Carlier, J; Diao, X; Eriksson, C; Huestis, MA; Josefsson, M; Konradsson, P; Kronstrand, R; Kugelberg, FC; Roman, M; Wohlfarth, A; Wu, X | 1 |
Andrade, AF; Gonzalez-Rodriguez, J; Mamo, SK | 1 |
Halberstadt, AL | 1 |
Angerer, V; Auwärter, V; Grumann, C; Hermanns-Clausen, M; Kithinji, J | 1 |
Dolan, SB; Forster, MJ; Gatch, MB | 1 |
Nisbet, LA; Scott, KS; Venson, R; Wylie, FM | 1 |
Ameline, A; Farrugia, A; Kintz, P; Raul, JS | 1 |
Anand, JS; Gil, D; Kała, M; Lechowicz, W; Waldman, W | 1 |
Cha, HJ; Jeon, SY; Kim, SJ; Kim, YH; Suh, SK | 1 |
Daunais, J; DeLorenzo, C; Gilling, N; Jorgensen, MJ; Kaplan, JR; Knudsen, GM; Kumar, D; Mann, JJ; Parsey, RV; Prabhakaran, J; Pratap, M; Zanderigo, F | 1 |
Lopez-Vallejo, F; Mariño Gaviria, DJ; Mendoza-Valencia, CY; Patiño Reyes, N; Sarmiento Gutiérrez, ÁE; Trespalacios Rodríguez, D | 1 |
Giurgea, GA; Gremmel, T; Hobl, EL; Koppensteiner, R; Löffler-Stastka, H; Luf, A; Schlager, O; Unterhumer, S; Wadowski, PP | 1 |
Holtkamp, M; Karst, U; Lützen, E; Pütz, M; Schmid, R; Sperling, M; Stamme, I | 1 |
Alfonso, M; Díaz de Greñu, B; Garrido, E; Gaviña, P; Lozano-Torres, B; Marcos, MD; Martínez-Máñez, R; Parra, M; Sancenón, F | 1 |
Kamińska, K; Malek, K; Świt, P | 1 |
González-Marín, A; Gołembiowska, K; Herian, M; Skawski, M; Sobocińska, MK; Wojtas, A | 1 |
Ameline, A; Kintz, P; Raul, JS | 1 |
Gołembiowska, K; Herian, M; Noworyta, K; Skawski, M; Sobocińska, MK; Wojtas, A | 1 |
Kocić, I; Schetz, A; Schetz, D | 1 |
Bysiek, A; Gołembiowska, K; Herian, M; Maćkowiak, M; Madej, K; Solarz, A; Wawrzczak-Bargiela, A; Wojtas, A | 1 |
2 review(s) available for dimethoxyphenylethylamine and 2-(4-iodo-2,5-dimethoxyphenyl)-n-(2-methoxybenzyl)ethanamine
Article | Year |
---|---|
2C-I-NBOMe, an "N-bomb" that kills with "Smiles". Toxicological and legislative aspects.
Topics: Designer Drugs; Dimethoxyphenylethylamine; Drug and Narcotic Control; Humans; Molecular Structure; Substance Abuse Detection; Substance-Related Disorders | 2015 |
Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.
Topics: Animals; Dimethoxyphenylethylamine; Ethylamines; Fever; Hallucinogens; Humans; Iodobenzenes; Mice; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Rhabdomyolysis; Seizures; Serotonin 5-HT2 Receptor Agonists; Structure-Activity Relationship; Vasoconstriction | 2017 |
38 other study(ies) available for dimethoxyphenylethylamine and 2-(4-iodo-2,5-dimethoxyphenyl)-n-(2-methoxybenzyl)ethanamine
Article | Year |
---|---|
Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.
Topics: Amines; Animals; Benzylamines; Brain; Dimethoxyphenylethylamine; Female; Injections, Intravenous; Ketanserin; Kinetics; Phenethylamines; Positron-Emission Tomography; Radioactive Tracers; Rats; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists; Swine | 2010 |
A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug.
Topics: Adolescent; Akathisia, Drug-Induced; Benzylamines; Chromatography, High Pressure Liquid; Designer Drugs; Dimethoxyphenylethylamine; Emergency Service, Hospital; Hallucinations; Humans; Male; Phenethylamines; Serotonin 5-HT2 Receptor Agonists | 2013 |
Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series.
Topics: Adult; Akathisia, Drug-Induced; Benzylamines; Dimethoxyphenylethylamine; England; Gas Chromatography-Mass Spectrometry; Hallucinations; Humans; Hypertension; Illicit Drugs; Male; Phenethylamines; Substance-Related Disorders; Tachycardia; Young Adult | 2013 |
2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.
Topics: Adolescent; Benzylamines; Biomarkers; Biotransformation; Designer Drugs; Dimethoxyphenylethylamine; Epilepsy, Tonic-Clonic; Female; Hallucinogens; Humans; Minnesota; Neurotoxicity Syndromes; Phenethylamines; Substance Abuse Detection; Treatment Outcome | 2014 |
NBOMe - a very different kettle of fish . . .
Topics: Benzylamines; Dimethoxyphenylethylamine; Humans; Lysergic Acid Diethylamide; Phenethylamines; Substance-Related Disorders | 2013 |
Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death.
Topics: Benzylamines; Bile; Brain Chemistry; Chromatography, Liquid; Designer Drugs; Dimethoxyphenylethylamine; Forensic Toxicology; Gastrointestinal Contents; Humans; Liver; Male; Molecular Structure; Paper; Phenethylamines; Postmortem Changes; Tandem Mass Spectrometry; Vitreous Body; Young Adult | 2014 |
Pathological findings in 2 cases of fatal 25I-NBOMe toxicity.
Topics: Adolescent; Benzylamines; Chromatography, Liquid; Contusions; Dimethoxyphenylethylamine; Ecchymosis; Female; Forensic Toxicology; Hallucinogens; Hematoma; Humans; Male; Mass Spectrometry; Phenethylamines; Purpura; Serotonin 5-HT2 Receptor Agonists; Substance-Related Disorders; Violence; Young Adult | 2014 |
NBOMe designer drug exposures reported to Texas poison centers.
Topics: Adolescent; Adult; Designer Drugs; Dimethoxyphenylethylamine; Humans; Male; Poison Control Centers; Substance-Related Disorders; Texas; Young Adult | 2014 |
Evolution of the NBOMes: 25C- and 25B- Sold as 25I-NBOMe.
Topics: Adolescent; Anisoles; Benzodiazepines; Central Nervous System Stimulants; Creatine Kinase; Designer Drugs; Dimethoxyphenylethylamine; Female; Humans; Hypnotics and Sedatives; Male; Mass Spectrometry; Mental Disorders; Muscle Rigidity; Phenethylamines; Receptor, Serotonin, 5-HT2A; Seizures; Serotonin 5-HT2 Receptor Agonists; Substance-Related Disorders | 2015 |
25I-NBOMe related death in Australia: a case report.
Topics: Adult; Australia; Designer Drugs; Dimethoxyphenylethylamine; Fatal Outcome; Female; Hallucinogens; Humans; Young Adult | 2015 |
Severe poisoning after self-reported use of 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, a novel substituted amphetamine: a case series.
Topics: Adolescent; Chromatography, High Pressure Liquid; Designer Drugs; Dimethoxyphenylethylamine; Female; Humans; Male; Poisoning; Tandem Mass Spectrometry; Young Adult | 2015 |
Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
Topics: Animals; Chromatography, Liquid; Designer Drugs; Dimethoxyphenylethylamine; Gas Chromatography-Mass Spectrometry; Humans; Male; Psychotropic Drugs; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Substance Abuse Detection; Tandem Mass Spectrometry; Toxicity Tests; Urinalysis | 2015 |
Near-lethal violent suicide attempt in a 15-year old adolescent with no prior psychiatric history following ingestion of 'N-Bomb' drug.
Topics: Adolescent; Dimethoxyphenylethylamine; Humans; Illicit Drugs; Male; Substance Abuse Detection; Substance-Related Disorders; Suicide, Attempted; Treatment Outcome | 2015 |
Fatal Intoxications with 25B-NBOMe and 25I-NBOMe in Indiana During 2014.
Topics: Adolescent; Anisoles; Dimethoxyphenylethylamine; Forensic Toxicology; Humans; Male; Phenethylamines | 2015 |
Identification of Metabolite Biomarkers of the Designer Hallucinogen 25I-NBOMe in Mouse Hepatic Microsomal Preparations and Human Urine Samples Associated with Clinical Intoxication.
Topics: Adult; Animals; Biomarkers; Designer Drugs; Dimethoxyphenylethylamine; Hallucinogens; Humans; Male; Mice; Mice, Inbred C57BL; Microsomes, Liver | 2015 |
Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.
Topics: Anisoles; Benzylamines; Chromatography, High Pressure Liquid; Dimethoxyphenylethylamine; Phenethylamines; Tandem Mass Spectrometry | 2015 |
A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State.
Topics: Adolescent; Dimethoxyphenylethylamine; Fatal Outcome; Humans; Male | 2015 |
Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases.
Topics: Adult; Anisoles; Benzodiazepines; Bombs; Chromatography, Liquid; Cluster Analysis; Dimethoxyphenylethylamine; Female; Hallucinations; Hallucinogens; Humans; Male; Phenethylamines; Tandem Mass Spectrometry; Young Adult | 2016 |
Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH.
Topics: Biotransformation; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Designer Drugs; Dimethoxyphenylethylamine; Hallucinogens; Humans; Metabolic Networks and Pathways; Microsomes, Liver; Phenols; Quaternary Ammonium Compounds; Serotonin 5-HT2 Receptor Agonists | 2017 |
25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
Topics: Animals; Benzylamines; Chromatography, High Pressure Liquid; Dimethoxyphenylethylamine; Hallucinogens; Hepatocytes; Humans; Male; Mice; Mice, Inbred C57BL; Phenethylamines; Substance Abuse Detection; Tandem Mass Spectrometry | 2017 |
Rapid Screening Method for New Psychoactive Substances of Forensic Interest: Electrochemistry and Analytical Determination of Phenethylamines Derivatives (NBOMe) via Cyclic and Differential Pulse Voltammetry.
Topics: Anisoles; Dimethoxyphenylethylamine; Electrochemical Techniques; Forensic Medicine; Hydrogen-Ion Concentration; Limit of Detection; Phenethylamines; Psychotropic Drugs | 2017 |
Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus.
Topics: Accidents; Adult; Analgesics; Chromatography, Liquid; Dimethoxyphenylethylamine; Humans; Male; Neurotoxicity Syndromes; Poisoning; Serotonin 5-HT2 Receptor Agonists; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2017 |
Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.
Topics: Animals; Anisoles; Benzylamines; Dimethoxyphenylethylamine; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; Locomotion; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Phenethylamines; Rats; Rats, Sprague-Dawley | 2017 |
Application of a Urine and Hair Validated LC-MS-MS Method to Determine the Effect of Hair Color on the Incorporation of 25B-NBOMe, 25C-NBOMe and 25I-NBOMe into Hair in the Rat.
Topics: Animals; Anisoles; Benzylamines; Chromatography, Liquid; Dimethoxyphenylethylamine; Hair; Hair Color; Phenethylamines; Rats; Substance Abuse Detection; Tandem Mass Spectrometry | 2017 |
Retrospective Demonstration of 25I-NBOMe Acute Poisoning Using Hair Analysis.
Topics: Chromatography, High Pressure Liquid; Designer Drugs; Dimethoxyphenylethylamine; Forensic Toxicology; Hair; Hallucinogens; Humans; Poisoning; Prevalence; Retrospective Studies; Serotonin 5-HT2 Receptor Antagonists; Tandem Mass Spectrometry | 2017 |
Severe clinical toxicity caused by 25I-NBOMe confirmed analytically using LC-MS-MS method.
Topics: Chromatography, Liquid; Dimethoxyphenylethylamine; Humans; Male; Psychotropic Drugs; Renal Dialysis; Rhabdomyolysis; Serotonin 5-HT2 Receptor Agonists; Tandem Mass Spectrometry; Young Adult | 2018 |
Abuse potential of 2-(4-iodo-2, 5-dimethoxyphenyl)N-(2-methoxybenzyl)ethanamine (25INBOMe); in vivo and ex vivo approaches.
Topics: Animals; Conditioning, Psychological; Dimethoxyphenylethylamine; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Reward; Self Administration; Substance-Related Disorders; Vocalization, Animal | 2019 |
In vivo PET Imaging of [11C]CIMBI-5, a 5-HT2AR Agonist Radiotracer in Nonhuman Primates.
Topics: Animals; Brain; Carbon Radioisotopes; Dimethoxyphenylethylamine; Haplorhini; Papio; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Agonists; Tissue Distribution | 2019 |
Mix of new substances psychoactive, NPS, found in blotters sold in two Colombian cities.
Topics: Administration, Sublingual; Colombia; Designer Drugs; Dimethoxyphenylethylamine; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drug Contamination; Drug Trafficking; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Paper; Substance-Related Disorders | 2019 |
Acute Limb Ischemia after Intake of the Phenylethylamine Derivate NBOMe.
Topics: Adult; Dimethoxyphenylethylamine; Hallucinogens; Humans; Ischemia; Male | 2019 |
Multimodal imaging of hallucinogens 25C- and 25I-NBOMe on blotter papers.
Topics: Benzylamines; Chromatography, High Pressure Liquid; Dimethoxyphenylethylamine; Hallucinogens; Lysergic Acid Diethylamide; Paper; Phenethylamines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2020 |
Nanosensor for Sensitive Detection of the New Psychedelic Drug 25I-NBOMe.
Topics: Dimethoxyphenylethylamine; Hallucinogens; Humans; Serotonin | 2020 |
2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review.
Topics: Benzylamines; Designer Drugs; Dimethoxyphenylethylamine; Europe; Hallucinogens; Humans; Phenethylamines | 2021 |
Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission.
Topics: Animals; Dimethoxyphenylethylamine; Dopamine; Frontal Lobe; Glutamic Acid; Hallucinogens; Male; Microdialysis; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin Receptor Agonists; Synaptic Transmission | 2020 |
The use of multiple keratinous matrices (head hair, axillary hair, and toenail clippings) can help narrowing a period of drug exposure: experience with a criminal case involving 25I-NBOMe and 4-MMC.
Topics: Chromatography, Liquid; Crime; Designer Drugs; Dimethoxyphenylethylamine; Hair; Humans; Keratins; Male; Methamphetamine; Nails; Substance Abuse Detection; Tandem Mass Spectrometry; Time Factors | 2021 |
Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe.
Topics: Animals; Brain Chemistry; Dimethoxyphenylethylamine; Dopamine; Frontal Lobe; Glutamic Acid; Hallucinogens; Locomotion; Male; Microdialysis; Rats; Rats, Wistar; Serotonin | 2021 |
A retrospective analysis of the "Neverending Trip" after administration of a potent full agonist of 5-HT2A receptor - 25I-NBOMe.
Topics: Adolescent; Adult; Chronic Disease; Depersonalization; Designer Drugs; Dimethoxyphenylethylamine; Female; Hallucinations; Hallucinogens; Humans; Male; Panic Disorder; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists; Young Adult | 2022 |
Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Brain; Dimethoxyphenylethylamine; DNA Damage; Dopamine; Glutamic Acid; Hallucinogens; Humans; Injections; Neuroglia; Oxidative Stress; Rats; Serotonin | 2022 |